Table 1.
Summary of clinical findings associated with eye injury in the study groups
| Clinical Findings | Study group | ||
|---|---|---|---|
|
| |||
| Non-injection | BSS | ||
|
| |||
| No. (%) | No. (%) | P | |
| Length of Laceration | |||
| ≤5 mm | 49 (44.1) | 68 (40.7) | 0.571 |
|
| |||
| >5 mm | 62 (55.9) | 99 (59.3) | |
|
| |||
| Location of Wound | |||
| Sclera | 15 (13.6) | 22 (13.2) | 0.207 |
|
| |||
| Cornea | 57 (51.8) | 103 (61.7) | |
|
| |||
| Sclera and Cornea | 38 (34.5) | 42 (25.1) | |
|
| |||
| Posterior Segment Involvement | 26 (23.9) | 23 (19.7) | 0.444 |
|
| |||
| Lens Injury | 51 (45.9) | 78 (46.7) | 0.901 |
|
| |||
| Injury to Repair Interval | |||
| ≤5 days | 4 (3.6) | 15 (9.0) | 0.080 |
|
| |||
| >5 days | 107 (96.4) | 151 (91.0) | |
|
| |||
| Presence of IOFB | 21 (18.9) | 25 (15.0) | 0.386 |
|
| |||
| Vitreous Prolapse | 45 (40.5) | 63 (37.7) | 0.637 |
|
| |||
| Site of Injection | |||
| Intracameral | 34 (30.6) | 70 (41.9) | 0.057 |
|
| |||
| Intravitreal | 77 (69.4) | 97 (58.1) | |
BSS, balanced salt solution; IOFB, intraocular foreign body; No., Number